Hematology/Oncology

Top Story

FDA accepts application for Opdivo-Yervoy, first immuno-oncology combination for lung cancer

June 22, 2018
Meeting NewsVideo

VIDEO: Lenvatinib-pembrolizumab shows promise in several cancer types

June 22, 2018
CHICAGO — Alton B. Kremer, MD, PhD, chief clinical officer and chief medical officer of the oncology business group at Eisai, spoke with HemOnc Today at ASCO…
Feature

MD Anderson Cancer Center’s colorectal cancer moon shot team designed to make fundamental changes in detection, treatment

June 21, 2018
The University of Texas MD Anderson Cancer Center’s Colorectal Cancer Moon Shot team is making significant strides in its effort to increase early detection…
Meeting News

Higher colon cancer risk tied to delayed colonoscopy after positive FIT

June 21, 2018
WASHINGTON — Patients who wait longer to undergo colonoscopy screening after a positive fecal immunochemical test are at higher risk for developing colorectal…
FDA News

FDA withdraws biosimilar draft guidance following public comments

June 21, 2018
The FDA has withdrawn a draft guidance intended to provide advice for biosimilar sponsors regarding the determination of similarity between the biosimilar and its…
More Headlines »
CME

EGFR-mutated NSCLC: Differentiating Options to Optimize Patient Care

This educational activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Lung cancer is the second most commonly diagnosed cancer within the United States and accounts for approximately 25% of…
More »
Video
Meeting News

VIDEO: ZUMA trials assess CAR T-cell therapy for lymphoma

June 16, 2018
More »
Resource Centers
ASCO Annual Meeting

ASCO Annual Meeting

CME

Multimodality Treatment Strategies for NSCLC: A Symposium at the US Oncology Annual Meeting

This activity is supported by an educational grant from Merck & Co., Inc.

Lung cancer is a leading cause of cancer death worldwide. Approximately 85% of diagnosed lung cancers are non-small…
More »
Current Issues
View the Current Issue
HemOnc Today